Cannabics Pharmaceuticals Overview

  • Status
  • Public

  • Employees
  • 10

Employees
  • Stock Symbol
  • CNBX

Stock Symbol
  • Investments
  • 2

  • Share Price
  • $3.75

  • (As of Wednesday Closing)

Cannabics Pharmaceuticals General Information

Description

CNBX Pharmaceuticals Inc is a biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing advanced HTS technology and personalized bioinformatics tools. The company's main focus is the development of therapies and biotechnological tools aimed at diverse ailments and human malignancies. The firm's main product is the RCC-33, an oral capsule for the treatment of colorectal cancer. Its advanced tools include delivery systems, personalized medicine diagnostics, and therapies based on Cannabinoid compounds.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Primary Office
  • 3 Bethesda Metro Center
  • Suite 700
  • Bethesda, MD 20814
  • United States
+1 (877) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cannabics Pharmaceuticals Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.75 $3.85 $3.00 - $21.67 $4.84M 1.26M 947.83 -$2.84

Cannabics Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-May-2022 FY 2021 31-Aug-2021 FY 2020 31-Aug-2020 FY 2019 31-Aug-2019
EV 7,320 24,017 24,366 30,718
Revenue 0 0 7 10
EBITDA (3,658) (2,971) (7,244) 1,340
Net Income (3,925) (3,194) (7,467) 1,133
Total Assets 966 3,079 2,219 15,183
Total Debt 1,605 872 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cannabics Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cannabics Pharmaceuticals‘s full profile, request access.

Request a free trial

Cannabics Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
CNBX Pharmaceuticals Inc is a biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing a
Biotechnology
Bethesda, MD
10 As of 2021
000.00
000000000 000.00

00000

labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris n
000000000000000
Basel, Switzerland
000000 As of 0000
00.000
00.00 0000-00-00
00000000000 00.000

0000 0

ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
0000000000000
Long Beach, CA
0 As of 0000
00.000
00000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cannabics Pharmaceuticals Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Roche Corporation Basel, Switzerland 000000 00.000 00000000000 00.000
0000 0000000000 Formerly VC-backed Long Beach, CA 0 00.000 00000000 00.000
000000 00000000000 Formerly VC-backed Norwood, MA 00 00.00 0000000000 00.00
00000000 0000000 Corporate Backed or Acquired Irvine, CA 0 000000&0
00000 000000000000 Corporation Vancouver, Canada 00 000.00 000000000 000.00
You’re viewing 5 of 13 competitors. Get the full list »

Cannabics Pharmaceuticals Patents

Cannabics Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190134123-A1 Novel system and method for microbiome profiling and modulation by means of cannabis administration Pending 08-Nov-2017 0000000000
US-20200408740-A1 Method for sensitivity testing of cannabinoids on patientderived tumor biopsies and ctcs Pending 04-Sep-2017 000000000000
CA-3074819-A1 Method for sensitivity testing of cannabinoids on patient-derived tumor biopsies and ctcs Pending 04-Sep-2017 000000000000
CA-3054392-A1 Cannabinoid compositions, methods of manufacture and use thereof Pending 24-Feb-2016 0000000000
US-20200268817-A1 Cannabinoid compositions, methods of manufacture and use thereof Pending 24-Feb-2016 A61K36/185
To view Cannabics Pharmaceuticals’s complete patent history, request access »

Cannabics Pharmaceuticals Executive Team (5)

Name Title Board Seat Contact Info
Eyal Barad Co-Founder, Board Member & Chief Executive Officer
Gabriel Yariv President, COO & Director
Uri Ben-Or Chief Financial Officer
Eyal Ballan Co-Founder & Chief Technology Officer
You’re viewing 4 of 5 executive team members. Get the full list »

Cannabics Pharmaceuticals Board Members (2)

Name Representing Role Since
0000 00000 Cannabics Pharmaceuticals Co-Founder, Board Member & Chief Executive Officer 000 0000
0000000 00000 Cannabics Pharmaceuticals President, COO & Director 000 0000
To view Cannabics Pharmaceuticals’s complete board members history, request access »

Cannabics Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cannabics Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cannabics Pharmaceuticals‘s full profile, request access.

Request a free trial

Cannabics Pharmaceuticals Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00000000 07-Feb-2019 00000 0000 Drug Discovery 0000 0000
Seedo 17-Sep-2018 Secondary Transaction - Private 00000 Machinery (B2B) 0000 0000
To view Cannabics Pharmaceuticals’s complete investments history, request access »

Cannabics Pharmaceuticals Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 17-Sep-2018 000000000 00000000 00000 Completed
  • 000000000 00000000
To view Cannabics Pharmaceuticals’s complete exits history, request access »